These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 12591966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG, Ishizawa S, Wu E, Weiss LM.
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ.
    Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
    [Abstract] [Full Text] [Related]

  • 6. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
    Maitra A, Murakata LA, Albores-Saavedra J.
    Am J Clin Pathol; 2001 May; 115(5):689-94. PubMed ID: 11345832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
    Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R.
    Cancer; 2002 Feb 25; 96(1):49-52. PubMed ID: 11836703
    [Abstract] [Full Text] [Related]

  • 18. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
    Sang W, Gulinar A, Wang CH, Sheng WQ, Maiweilidan Y, Zhang W.
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug 25; 42(8):538-42. PubMed ID: 24246920
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M, Sun L, Lai JZ, Shi H, Mei K, He X, Jin X, Lai J, Cao D.
    Pathol Res Pract; 2018 Oct 25; 214(10):1707-1712. PubMed ID: 30196987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.